COVID-19 / Coronavirus

CMUH Smart Medicine System Assisted the ARDS Specialist Team Successfully Reversed the Patient's Critical Condition

2023-05-15 20:30 876

TAICHUNG,Taiwan, May 15, 2023 /PRNewswire/ -- After the worldwide COVID-19 pandemic, most people suffered from mild disease, and "Acute Respiratory Distress Syndrome (ARDS)" is common for those critical COVID-19 patients. The 46-year-old of Ms. Chang, who had hypertension and nephropathy, accepte...

MGI Empowers the Completion of Nearly 60,000 Samples for The Million Microbiome of Humans Project

2023-05-15 16:29 1131

SHENZHEN, China, May 15, 2023 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, recently shared that a total of nearly 60,000 samples have been sequenced among 21 institutes and over 10 participating nations throughoutEurope, ...

Zhongchao Inc. Announces Strategic Cooperation with Ximalaya

2023-05-12 20:00 1492

SHANGHAI, May 12, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Beijing Zhongchao Boya Medical Technology Co., Ltd. ("Boya M...

CytoMed Therapeutics to Ring Nasdaq Closing Bell

2023-05-11 21:00 2616

SINGAPORE, May 11, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited ("CytoMed" or the "Company") (Nasdaq: GDTC), a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel allogeneic cell-based immunotherapies for the treatment of human cancers, will ...

Innovent Announces Phase 2 Clinical Study of Higher dose 9 mg Mazdutide (IBI362) in Chinese Adults with Obesity Achieved the 24-Week Primary Endpoint

2023-05-11 08:45 2636

ROCKVILLIE, Md. and SUZHOU, China, May 11, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...

Fosun Pharma Participates in BEYOND Expo 2023 to Showcase Its Innovative R&D Achievements

2023-05-10 22:57 1831

MACAU, May 10, 2023 /PRNewswire/ -- From May 10 to 12, 2023, the 3rd BEYOND International Technology Innovation Expo — also known as BEYOND Expo 2023is being held at the Venetian Macau Convention and Exhibition Center. This year is the third consecutive year that Fosun Pharma (stock code: 600196....

CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology

2023-05-09 22:07 1603

SINGAPORE, May 9, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (Nasdaq: GDTC) ("CytoMed" or the "Company"), a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel allogeneic cell-based immunotherapies for the treatment of human cancers, today ...

Ascletis Announces China NMPA Approval of Conducting a Phase IIa Clinical Trial for ASC10 to Treat Respiratory Syncytial Virus Infection

2023-05-08 16:50 1559

--Respiratory syncytial virus (RSV) infection treatment remains huge unmet medical needs and there is no effective drug for treatment globally so far --Dosage of 800 mg ASC10, twice daily was selected to conduct a Phase IIa study in patients with RSV infection --Preclinical research showed that ...

Vice President of Tencent HealthCare Zhang Yu: Create the "flywheel" of software development effectiveness and efficiency to drive continuous innovation in healthcare

2023-05-05 21:10 1830

BEIJING, May 5, 2023 /PRNewswire/ -- The digital era has ushered rapid changes in software development philosophy and process, as well as technologies and tools. For healthcare, the digital transformation of the industry allows for rapid response to major public health emergencies, stable operati...

New report by the Global Hygiene Council (GHC) highlights critical role of hygiene in the fight against antimicrobial resistance and future pandemics

2023-05-05 20:14 2165

LONDON, May 5, 2023 /PRNewswire/ -- A new report launched today by the Global Hygiene Council (GHC), an independent council of leading experts in hygiene and infection prevention, calls for urgent action to prioritise hygiene in home and community settings in pandemic preparedness plans beyond CO...

Recall Notice - SD Biosensor, Inc. requests discontinuation of use and disposal of specific Pilot™ COVID-19 At-Home Tests in the United States due to microbial contamination in the liquid buffer solution

2023-05-05 04:00 1480

SEOUL, South Korea, May 4, 2023 /PRNewswire/ -- SD Biosensor, Inc. today is requesting that consumers stop using and dispose of specific Pilot COVID-19 At-Home Tests inthe United States because potentially harmful bacteria were found in the tube with liquid inside (pouch 2 of the kits). The affe...

DetectedX's Radiology Online Learning Centre Passes 4,500 Users

2023-05-04 23:25 1454

DetectedX will Showcase New Interactive Educational Technology at SBI NATIONAL HARBOR, Md., May 4, 2023 /PRNewswire/ -- DetectedX, the leaders in intelligent interactive educational technology, announced today that it has surpassed 4,500 users of its Radiology Online Learning Centre. Users, whic...

National Comprehensive Cancer Network Honors Cancer Leaders who Guide the Future of Care

2023-05-04 23:00 1962

Theresa J. Franco, Fred & Pamela Buffett Cancer Center; F. Marc Stewart, City of Hope National Medical Center;Douglas E. Wood, UW Medicine Fred Hutchinson Cancer Center; andDonna Powell, NCCN, presented with awards during NCCN 2023 Annual Conference. PLYMOUTH MEETING, Pa., May 4, 2023 /PRNewswir...

Univar Solutions and Solvay Strengthen Partnership with New, Exclusive Lubricants and Metalworking Fluids Agreement in China

2023-05-03 23:37 1716

Expanded global relationship brings an array of specialty ingredients with a diverse range of applications to customers seeking more reliable and sustainable metalworking fluid solutions DOWNERS GROVE, Ill., May 3, 2023 /PRNewswire/ -- Univar Solutions China Company Limited, a subsidiary of Univ...

Grand and People's Choice Stevie® Award Winners Announced in 2023 Asia-Pacific Stevie Awards

2023-05-02 15:37 1744

Cisco Systems Named Organization of the Year; More Than 9,300 Were Cast in the Public Vote FAIRFAX, Va., May 2, 2023 /PRNewswire/ -- The Stevie® Awards, organizer of the world's premier business awards programs, announced the winners of five Grand Stevie Award trophies, plus nine winners of a Pe...

Health Canal Survey: Why Older Adults are Hesitant to Receive the Bivalent Booster Shot

2023-05-01 22:00 1259

New survey by Health Canal reveals that personal health and safety concerns drive older adults' intentions and attitudes toward bivalent booster shots GROVE CITY, Ohio, May 1, 2023 /PRNewswire/ -- The CDC has recommended the bivalent mRNA COVID-19 vaccines sinceSep...

IMG-004 demonstrated extended half-life and durable pharmacodynamic characteristics in a Phase 1 study

2023-04-28 17:00 1130

SAN DIEGO, SHANGHAI and SYDNEY, April 28, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") today announced positive topline results from a Phase 1 study evaluating IMG-004 in healthy participants. IMG-004 is a potent, non-covalent, reversible, and brain permeable third-generation Br...

Paying it forward: SM marks another year of positive community impact

2023-04-28 16:12 2528

PASAY CITY, Philippines, April 28, 2023 /PRNewswire/ -- Glenn Paul Añover Embodo is among the 'Yolanda' scholars helped by SM Foundation, Inc. of the SM Group, following the devastation of the super typhoon in the country in 2013.  More ...

Brii Bio Publishes 2022 Environmental, Social and Governance Report

2023-04-28 09:00 1738

Brii Bio receives an "A" grade in the latest MSCI ESG Rating DURHAM, N.C. and BEIJING, April 28, 2023 /PRNewswire/ -- Brii Biosciences Limited  ("Brii Bio" or the "Company," stock code: 2137.HK), a biotechnology company developing therapies to improve patient health ...

RNAimmune Receives FDA Clearance of Investigational New Drug Application for Phase 1 Trial of RV-1730 COVID-19 Booster Vaccine

2023-04-28 00:29 1825

GERMANTOWN, Md. and GUANGZHOU, China, April 28, 2023 /PRNewswire/ -- RNAimmune, Inc.(the "Company" or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, today announced that the Company has received a clearance from the Uni...

12345 ... 216